PTTG expression may correlate with aggressiveness across different pituitary adenoma types (72), but it’s role as a molecular marker for clinical use in somatotroph adenoma characterization and targeted treatment warrants further investigation. The gene discussed is PTTG1; the disease is acromegaly.